E57D (p.Glu57Asp) variant of CDK9 (Cyclin-dependent kinase 9)
E57D (p.Glu57Asp) in CDK9 (Cyclin-dependent kinase 9) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.33 / 1. The record also includes population frequency data and structural context.
E57D (p.Glu57Asp) variant details
- p.Glu57Asp
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.327
- REVEL 0.23
- CADD 23.50
- PolyPhen-2 0.74
- SIFT 0.04
- UniProt: Variant assessed as somatic; moderate impact.
- Population evidence available
- Structural context available